Likewise, the mRNA results showed that SM-3 substantially reduced the levels of the transcription factors OCT4, NANOG, and SOX2 compared to Res-treated lung cancer cells, including H292 and H460 cells (Fig. S3G, S4G). This evidence concerns the gene NANOG and lung cancer.